Work

A phase II trial of preoperative FOLFIRINOX followed by gemcitabine-based chemoradiotherapy in patients with borderline resectable pancreatic ductal adenocarcinoma (BR PDAC).

Year: 2020

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2020.38.15_suppl.4638

Authors: Michael Wysota, Amanda Jirgal, Ana Acuna-Villaorduna, Shankar Viswanathan, Andreas Kaubisch, Eswar Gadde, Rafi Kabarriti, Sanjay Goel, Jennifer W. Chuy

Institutions: Montefiore Medical Center, Albert Einstein College of Medicine

Language: English

Topic: Pancreatic and Hepatic Oncology Research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W3029926569

Cites:

Cited by:

Related to: 10